| Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver (NCT00301106) | Max Sung | 2005-10-01 |
| Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer (NCT00280930) | Dana-Farber Cancer Institute | 2005-10-01 |
| Neoadjuvant Treatment of Breast Cancer (NCT00254592) | University of California, Irvine | 2005-10-01 |
| Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients (NCT00327288) | AmpliMed Corporation | 2005-10-01 |
| Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. (NCT00287482) | Women and Infants Hospital of Rhode Island | 2005-10-01 |
| Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer (NCT00291083) | Carol Fabian, MD | 2005-10-01 |
| Improving Communication With Patients With Breast Cancer (NCT00276822) | Northwestern University | 2005-10-01 |
| PV-10 Chemoablation of Recurrent Breast Carcinoma (NCT00237354) | Provectus Pharmaceuticals | 2005-10-01 |
| Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer (NCT00262834) | National Cancer Institute (NCI) | 2005-10-01 |
| Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer (NCT00493350) | M.D. Anderson Cancer Center | 2005-10-01 |
| A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer (NCT00475670) | Hoffmann-La Roche | 2005-10-01 |
| A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine (NCT00246090) | Eisai Inc. | 2005-10-01 |
| Psychosocial Study on Breast Cancer Risk Assessment (NCT00234715) | University Health Network, Toronto | 2005-10-01 |
| Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer (NCT00295893) | City of Hope Medical Center | 2005-09-27 |
| Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer (NCT00203502) | University of Arkansas | 2005-09-01 |
| S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer (NCT00217659) | SWOG Cancer Research Network | 2005-09-01 |
| Paravertebral Block for Breast Surgery (NCT00131170) | University of Aarhus | 2005-09-01 |
| Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer (NCT00256360) | Universitaire Ziekenhuizen KU Leuven | 2005-09-01 |
| Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy (NCT00247650) | Novartis | 2005-09-01 |
| Psychological and Social Factors and Risk Chronic Pain After Surgery in Women With Breast Cancer (NCT00466830) | Institut Bergonié | 2005-09-01 |
| Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer (NCT00227656) | M.D. Anderson Cancer Center | 2005-09-01 |
| Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00128622) | H. Kim Lyerly | 2005-09-01 |
| Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment (NCT00122356) | Barwon Health | 2005-09-01 |
| Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer (NCT00232479) | University of Miami | 2005-09-01 |
| Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) (NCT00712985) | Milton S. Hershey Medical Center | 2005-09-01 |
| Use of a Radiolucent Pad to Reduce Mammography Among African Americans (NCT00594282) | University of Kansas | 2005-09-01 |
| Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer (NCT00465673) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-09-01 |
| Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer (NCT00321633) | University College London Hospitals | 2005-09-01 |
| A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer (NCT00235235) | Hoosier Cancer Research Network | 2005-09-01 |
| Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients (NCT00268918) | Dana-Farber Cancer Institute | 2005-09-01 |
| Evaluating Tools for Health Promotion and Disease Prevention (NCT00164658) | Centers for Disease Control and Prevention | 2005-09-01 |
| Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer (NCT00532285) | National Cancer Center, Korea | 2005-09-01 |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT01172028) | University of Arizona | 2005-09-01 |
| Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer (NCT00201864) | Ohio State University Comprehensive Cancer Center | 2005-09-01 |
| Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole (NCT00376740) | Soroka University Medical Center | 2005-09-01 |
| Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer. (NCT00409071) | Centre Leon Berard | 2005-09-01 |
| Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer (NCT00294151) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2005-09-01 |
| Wellbutrin XL, Major Depressive Disorder and Breast Cancer (NCT00234195) | Thomas Jefferson University | 2005-09-01 |
| Quantitative Dynamic Contrast Enhanced Breast MRI (NCT00582764) | Memorial Sloan Kettering Cancer Center | 2005-09-01 |
| Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer (NCT00193206) | SCRI Development Innovations, LLC | 2005-09-01 |
| Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer (NCT00107484) | Virginia Commonwealth University | 2005-09-01 |
| Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens (NCT00149214) | Eli Lilly and Company | 2005-09-01 |
| Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer (NCT00179309) | National Cancer Institute (NCI) | 2005-09-01 |
| Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer (NCT00107510) | Alliance for Clinical Trials in Oncology | 2005-08-01 |
| STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot) (NCT00126360) | St George Hospital, Australia | 2005-08-01 |
| Pre-biopsy With Dynamic Acquisitions (NCT00943644) | Mayo Clinic | 2005-08-01 |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors (NCT00433407) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions (NCT00262899) | Georgetown University | 2005-08-01 |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease (NCT00898508) | City of Hope Medical Center | 2005-08-01 |
| Reflexology: An Intervention for Advanced Breast Cancer (NCT01577420) | Michigan State University | 2005-08-01 |
| XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer (NCT00127933) | Hoffmann-La Roche | 2005-08-01 |
| Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects (NCT01183832) | Centre Oscar Lambret | 2005-08-01 |
| Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer (NCT00719173) | UNC Lineberger Comprehensive Cancer Center | 2005-08-01 |
| Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer (NCT00296010) | ETOP IBCSG Partners Foundation | 2005-08-01 |
| S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer (NCT00107276) | SWOG Cancer Research Network | 2005-08-01 |
| Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4) (NCT01064635) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2005-08-01 |
| Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts (NCT00620373) | Mayo Clinic | 2005-08-01 |
| ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer (NCT00110084) | Mayo Clinic | 2005-08-01 |
| Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2 (NCT00383604) | Stanford University | 2005-07-01 |
| Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer (NCT00193726) | Sudeep Gupta | 2005-07-01 |
| Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers (NCT00291473) | Ludwig Institute for Cancer Research | 2005-07-01 |
| Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women (NCT00900367) | Brigham and Women's Hospital | 2005-07-01 |
| The Role of Serotonin in Hot Flashes After Breast Cancer (NCT00228943) | Indiana University | 2005-07-01 |
| Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer (NCT00283608) | Mayo Clinic | 2005-07-01 |
| Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer (NCT00182793) | City of Hope Medical Center | 2005-07-01 |
| Mono Efficacy of Capecitabine (MoniCa) (NCT00196820) | GBG Forschungs GmbH | 2005-07-01 |
| Patient Navigation in the Safety Net:CONNECTeDD (NCT00613275) | Boston Medical Center | 2005-07-01 |
| S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. (NCT00127205) | SWOG Cancer Research Network | 2005-07-01 |
| Physical Activity Promotion in Breast Cancer Survivors (NCT00221221) | University of Alberta | 2005-07-01 |
| Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease (NCT00165412) | Dana-Farber Cancer Institute | 2005-07-01 |
| Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer (NCT00971945) | Bristol-Myers Squibb | 2005-06-30 |
| Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer (NCT00323908) | Carol Fabian, MD | 2005-06-01 |
| Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients (NCT00241462) | AstraZeneca | 2005-06-01 |
| Acupuncture for Aromatase Inhibitor Induced Joint Pain (NCT00826397) | Columbia University | 2005-06-01 |
| Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer (NCT00121134) | Harold J. Burstein, MD, PhD | 2005-06-01 |
| Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer (NCT00161291) | University of Alabama at Birmingham | 2005-06-01 |
| Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to Present (NCT00534755) | King Faisal Specialist Hospital & Research Center | 2005-06-01 |
| A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients (NCT00190671) | Eli Lilly and Company | 2005-06-01 |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer (NCT00900835) | City of Hope Medical Center | 2005-06-01 |
| Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer (NCT00438477) | M.D. Anderson Cancer Center | 2005-06-01 |
| A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer (NCT00544986) | AstraZeneca | 2005-06-01 |
| Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model (NCT00468585) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| Teleconference Group: Breast Cancer in African Americans (STORY) (NCT01339351) | University of South Carolina | 2005-06-01 |
| Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas (NCT02794558) | InSightec | 2005-06-01 |
| Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery (NCT00605670) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer (NCT00121836) | Hoffmann-La Roche | 2005-06-01 |
| Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer (NCT00897208) | Mayo Clinic | 2005-05-20 |
| Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer (NCT00569543) | University of Nebraska | 2005-05-11 |
| Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer (NCT00255788) | NCIC Clinical Trials Group | 2005-05-10 |
| Pilot Study of 18F Fluoropaclitaxel (FPAC) (NCT00572598) | Virginia Commonwealth University | 2005-05-01 |
| Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer (NCT00329017) | Carol Fabian, MD | 2005-05-01 |
| Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy (NCT00214292) | University of Wisconsin, Madison | 2005-05-01 |
| Lymphedema Prevention in Breast Cancer (NCT00760123) | University of Alcala | 2005-05-01 |
| Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer (NCT00193180) | SCRI Development Innovations, LLC | 2005-05-01 |
| Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer (NCT00638391) | AstraZeneca | 2005-05-01 |
| How Breast Conservative Surgery (BCS) Affects Women's Daily Activities On Post-Operation 2 Days? (NCT00265213) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2005-05-01 |
| Docetaxel in Treating Older Women With Metastatic Breast Cancer (NCT00104624) | UNICANCER | 2005-05-01 |
| Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer (NCT00161265) | University of Michigan Rogel Cancer Center | 2005-05-01 |
| Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299) (NCT00203372) | Translational Oncology Research International | 2005-05-01 |
| Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status (NCT00383500) | Stanford University | 2005-05-01 |